Category: Nursing

  • Please provide an answer that is 100% original and do not copy the answer to thi

    Please provide an answer that is 100% original and do not copy the answer to this question from any other website since I am already well aware of this. I will be sure to check this.
    Please be sure that the answer comes up with way less than 18% on Studypool’s internal plagiarism checker since anything above this is not acceptable according to Studypool’s standards. I will not accept answers that are above this standard.
    No AI or Chatbot! I will be sure to check this.
    I attached helpful sources for you to use. Also, The particular topic that I will be focusing on is decreasing hypertension in patients.
    Please be sure to not provide an introduction or conclusion paragraph since this is going to be a part of a much larger paper.
    Prompt: Discuss measures you could use to understand your identified quality issue ( decreasing patient’s elevated b/p) by identifying one structure measure, one process measure, one outcome measure, and one customer experience measure that could be used to examine this issue
    Requirements: 200-500 Words Times New Roman Size 12 Font Double-Spaced APA Format Excluding the Title and Reference Pages | .doc file
    Please provide an answer that is 100% original and do not copy the answer to this question from any other website since I am already well aware of this. I will be sure to check this.
    Please be sure that the answer comes up with way less than 18% on Studypool’s internal plagiarism checker since anything above this is not acceptable according to Studypool’s standards. I will not accept answers that are above this standard.
    Please be sure to not provide an introduction or conclusion paragraph since this is going to be a part of a much larger paper.
    Please be sure to carefully follow the instructions
    No plagiarism & No Course Hero & No Chegg. The assignment will be checked for originality via the Turnitin plagiarism tool.
    Please be sure to include at least on in-text citation in each paragraph

  • What is the difference between qualitative and quantitative research methods? Gi

    What is the difference between qualitative and quantitative research methods? Give an example of each.
    Submission Instructions:
    Your initial post should be at least 500 words , formatted and cited in current APA style with support from at least 2 academic sources within the last 5 years .

  • In this assignment, you will address each of the following: Review Exhibit 22.1

    In this assignment, you will address each of the following:
    Review Exhibit 22.1 and Exhibit 22.2 in the textbook. In your assignment, describe how heat and cold therapy has been used culturally and across various populations around the world. Define the benefits and their impact on healing and health promotion in a patient with chronic pain. Describe a patient in your care for whom heat and/or cold therapy was valuable or could have been of value.
    Please refer to the learning materials and videos to help you answer the assignment.
    Please review the Writing Assignment Rubric for criteria that exceed expectations. You must have at least 4–5 scholarly references to support your statements to exceed expectations. Please ensure your work adheres to the Communication Policies.

  • Discussion 1 Assessment Descriiption Identify a fungal infection and, using the

    Discussion 1
    Assessment Descriiption
    Identify a fungal infection and, using the treatment guidelines, select a medication to treat the fungal infection.
    1) Share the mechanism of action of this medication
    2) Monitoring
    3) Side effects, and drug interactions, including interactions with CAM.
    4) Elaborate on one drug-drug interaction
    5) Devise a plan to clinically manage the interaction.
    6) Discuss evidence and treatment guidelines to determine appropriate therapeutic options for a patient with a fungal infection.
    Include the name of the medication in the subject line so that the medications can be followed. Include references in APA format.
    (Avoid using***Aspergillus/Voriconazole and Paracoccidioidomycosis please)
    Discussion 2
    Assessment Descriiption
    Select one of the three scenarios below and select a medication.
    1) Discuss the ethnic, cultural, or genetic differences in the uses for the treatment of that infection.
    2) Share the mechanism of action of this medication
    3) Monitoring
    4) Side effects and drug interactions.
    5) In addition, share a clinical trial that supports the use of this agent.
    Include the name of the medication in the subject line so that the medications can be followed. Include references in APA format.
    Scenario 1: Choose a medication that has a mechanism of action of disruption of bacterial synthesis.
    Scenario 2: Choose a medication that used to treat urinary tract infections.
    Scenario 3: Choose a medication that is used to treat tuberculosis.
    (Avoid using*** Rifampin, Bactrim, and Nitrofurantoin please)

  • For this assignment, put yourself in the role of a Nurse Case Manager (NCM. Gene

    For this assignment, put yourself in the role of a Nurse Case Manager (NCM. Generate a case report on a patient encountered at your current job or during your clinicals in nursing school, who experienced an acute exacerbation of an underling chronic physical illness. Use the same patient throughout the entire Assignment 1. Select a patient you cared for who required or would have benefited from having a NCM at both the patient and the system levels. The report will be narrated (written in paragraphs, following APA [7th ed.] guidelines for writing papers), not outlined or bulleted.
    See grading rubric below.
    • Patient profile: gender, age, ethnicity, socioeconomic status-including work status, financial sources, insurance coverage, living arrangements (needed for proper discharge planning), e.g., type of housing- one, two or more levels, any stairs etc.; marital status; social support.
    • Acute and chronic illness description: medical diagnosis for the chronic illness, length of time with diagnoses, primary medical treatment (pharmacologic and non-pharmacologic);
    NCM identified priority patient need/problem (at either the System or patient-level) affecting the pts health care; NCM identified priority intervention the NCM must implement to accomplish set goals, using NCM strategies (see below).
    • Patient self-care and self-management capacity: summary of self-care capacity and specific self-management skills required for patient to adhere to recommended treatment and general statement about the patient’s functional status in terms of ADL and IADL, including patient’s ability to drive. If patient does not drive, who drives and are they willing to assist.
    • Patient pattern of health care utilization: summary statement about the patient’s usual use of both primary and specialty care to manage chronic condition; include any acute care (urgentPage
    <
    general statement about the patient's functional status in terms of ADL and lADL, including patient's ability to drive. If patient does not drive, who drives and are they willing to assist.
    • Patient pattern of health care utilization: summary statement about the patient's usual use of both primary and specialty care to manage chronic condition; include any acute care (urgent care, ED, and hospital) accessed by the patient as well, and any supportive care (e.g., home health or any other system of care in the community).
    When writing your case report paper, select from the following NCM strategies that would lead you to accomplish the goals/intervention set forth in the NCM plan to address the identified priority patient problem/need. You can use one or more NCM strategies if necessary. The system and patient level NCM strategies must be relevant for your patient. Provide justification for the selection of the NCM strategies (e.g. if you say you will use teaching disease and treatment strategy to educate your patient, then the justification would be that the patient lacks self-management skills or lacks an understanding of the disease or treatment).
    Partnership:
    Clinical:
    * Empowering patients; Supporting transitions
    Assessing health; Monitoring physiologic stability; Planning health care at patient level; Using specific nursing interventions
    Education:
    * Teaching disease and treatment, Coaching symptom self-management*, Coaching caregiving for family
    Communication:
    Managed Care:
    Advocacy; Team communication, Therapeutic communication Risk Management (* risk stratification), Utilization Management.
    Planning and coordinating, Resource Management, Cost management
    *Key NCM Strategies

  • Technology and innovation can transform complex, ever-evolving healthcare enviro

    Technology and innovation can transform complex, ever-evolving healthcare environments and it is students who are often on the forefront with creative thoughts and ideas.The University of Cincinnati, College of Nursing is guided by the vision to lead and impact healthcare through the leveraging of technology and innovation.For this assignment, students will reflect on their clinical experiences in the outpatient environment and consider innovative thoughts and ideas which could positively impact the patient or provider.Thoughts and ideas are endless and can apply to the nurse practitioner role or the patient perspective.The students should consider what they have seen in the clinical setting that needs improved or revised?Is there an app that could help the patient or the provider?Perhaps, the student has an idea to redesign a piece of equipment or invent a tool for use in the clinical setting. This assignment encourages students to identify problems in the clinical setting and think of innovative solutions to solve the problem.The student should introduce their innovative thoughts and ideas through a Flipgrid video discussion and share with other students and indicate the following:
    Why is this innovative idea needed and how will it benefit the healthcare industry as a whole?
    How will this innovation impact the provider?
    How will it impact the patient?
    Consider the advantages and disadvantages to the student’s idea (i.e. consider cost, implementation, etc.)

  • he purpose of assignment is to provide experience and feedback with the developm

    he purpose of assignment is to provide experience and feedback with the development of a clinical question of interest to you using the PICO format along with designing and documenting the results of a search for scientific literature related to the clinical question. This assignment is intended to allow you to show evidence of achievement of:
    CLO2: Develop evidenced-based practice questions using PICO format.
    Requirements
    This scholarly paper is due on day 7 of week 5. An APA template is provided which describes the expectations for each section of this scholarly paper. Graduate level writing is expected. The following rubric will be used to score this assignment.
    Please use the attached APA Template as a guide for this assignment:

  • THE ASSIGNMENT: 5 PAGES Examine Case Study: A Puerto Rican Woman With Comorbid A

    THE ASSIGNMENT: 5 PAGES
    Examine Case Study: A Puerto Rican Woman With Comorbid Addiction. You will be asked to make three decisions concerning the medication to prescribe to this client. Be sure to consider factors that might impact the client’s pharmacokinetic and pharmacodynamic processes.
    At each decision point, you should evaluate all options before selecting your decision and moving throughout the exercise. Before you make your decision, make sure that you have researched each option and that you evaluate the decision that you will select. Be sure to research each option using the primary literature.
    Introduction to the case (1 page)
    Briefly explain and summarize the case for this Assignment. Be sure to include the specific patient factors that may impact your decision making when prescribing medication for this patient.
    Decision #1 (1 page)
    Which decision did you select?
    Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
    Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
    What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
    Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.
    Decision #2 (1 page)
    Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
    Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
    What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
    Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.
    Decision #3 (1 page)
    Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
    Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
    What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
    Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.
    Conclusion (1 page)
    Summarize your recommendations on the treatment options you selected for this patient. Be sure to justify your recommendations and support your response with clinically relevant and patient-specific resources, including the primary literature.
    Stahl, S. M. (2021). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (5th Ed.) Cambridge University Press.
    Chapter 13, “Impulsivity, Compulsivity, and Addiction” (pp. 538-578)
    Substance Abuse and Mental Health Services Administration. (1999). Treatment of adolescents with substance use disorders: Treatment improvement protocol seriesLinks to an external site., no. 32. http://www.ncbi.nlm.nih.gov/books/NBK64350/
    Chapter 1, “Substance Use Among Adolescents”
    Chapter 2, “Tailoring Treatment to the Adolescent’s Problem”
    Chapter 7, “Youths with Distinctive Treatment Needs”
    University of Michigan Health System. (2016). Childhood trauma linked to worse impulse control. Journal of Psychosocial Nursing & Mental Health ServicesLinks to an external site., 54(4), 15.
    Grant, J. E., Odlaug, B. L., & Schreiber, L. N. (2014). Pharmacological treatments in pathological gambling. British Journal of Clinical PharmacologyLinks to an external site., 77(2), 375–381. https://doi.org/10.1111/j.1365-2125.2012.04457.x
    Hulvershorn, L. A., Schroeder, K. M., Wink, L. K., Erickson, C. A., & McDougle, C. J. (2015). Psychopharmacologic treatment of children prenatally exposed to drugs of abuse. Human PsychopharmacologyLinks to an external site., 30(3), 164–172. https://doi.org/10.1002/hup.2467
    Loreck, D., Brandt, N. J., & DiPaula, B. (2016). Managing opioid abuse in older adults: Clinical considerations and challenges. Journal of Gerontological NursingLinks to an external site., 42(4), 10–15. https://doi.org/10.3928/00989134-20160314-04
    Salmon, J. M., & Forester, B. (2012). Substance abuse and co-occurring psychiatric disorders in older adults: A clinical case and review of the relevant literature. Journal of Dual DiagnosisLinks to an external site., 8(1), 74–84. https://doi.org/10.1080/15504263.2012.648439
    Sanches, M., Scott-Gurnell, K., Patel, A., Caetano, S. C., Zunta-Soares, G. B., Hatch, J. P., Olvera, R., Swann, A. C., & Soares, J. C. (2014). Impulsivity in children and adolescents with mood disorders and unaffected offspring of bipolar parents. Comprehensive PsychiatryLinks to an external site., 55(6), 1337–1341. https://doi.org/10.1016/j.comppsych.2014.04.018
    naltrexone (revia/vivitrol)
    naloxone
    acamprosate
    DisulfiramLupi, M., Martinotti, G., Acciavatti, T., Pettorruso, M., Brunetti, M., Santacroce, R., Cinose, E., Di Iorio, G., Di Nicola, M., & Di Giannantonio, M. (2014). Pharmacological treatments in gambling disorder: A qualitative review. Biomed Research International, 2014Links to an external site.. https://doi.org/10.1155/2014/537306
    Case Study: A Puerto Rican Woman with Comorbid AddictionLinks to an external site. Note: This case study will serve as the foundation for this week’s Assignment.
    Decision Point One
    Antabuse (disulfiram) 250 mg orally every morning
    RESULTS OF DECISION POINT ONE
    Client returns to clinic in four weeks
    Mrs. Perez reports to the office complaining of sedation, fatigue, and a “metallic taste” in her mouth, which “seems to be going away.” She also reports that she had just one drink about 5 days after starting the drug and thought that she would “die.” She reports that her face was red, and she felt that her heart would “pound right out of my chest.” Mrs. Perez also reports that she continues to visit the casino but has not been spending as much money there. She has noticed that her cigarette smoking is increasing Decision Point Two
    Continue current dose of Antabuse and begin Wellbutrin (bupropion) XL 150 mg orally daily RESULTS OF DECISION POINT TWO
    Client returns to clinic in four weeks
    Mrs. Perez reports that the side effects of the Antabuse are “gone” and that she is feeling much better
    She reports that she is still smoking but that “it has dropped to only a couple of cigarettes a day.” She still reports that she is visiting the casino but is not spending “as much money” as she had been in the past
    Decision Point Three
    Maintain current doses of each medication and refer to counseling for her gambling Guidance to Student
    Sedation/fatigue is a common complaint of people who take Antabuse, the best approach would be to change the administration time to the evening. The “metallic” taste in Mrs. Perez’s mouth is also another side effect that lessens and may fully go away with the passage of time. When a person taking disulfiram ingests alcohol, they will probably experience “flushing,” tachycardia, nausea, and vomiting.
    At this point, you should maintain the current dose of each medication and refer the client to a counselor. Recall that there are no FDA-approved medications for the treatment of gambling addiction, and counseling is the mainstay of treatment for this particular disorder. Nothing indicates an increase the Wellbutrin. Recall that it could take as long as 12 weeks for this medication to exert its full therapeutic effect. Cognitive behavioral principles can also be employed to help Mrs. Perez stop smoking, in addition to the Wellbutrin.
    Although controversy exists in the literature regarding how long to maintain a client on Antabuse, 8 weeks is probably too soon to consider discontinuation. Needs to include 5 APA references. Thank you!

  • A nurse colleague uses his personal cell phone to take a photo of a patient’s wo

    A nurse colleague uses his personal cell phone to take a photo of a patient’s wound and then sends a message with the photo to the primary care provider via a text. Please consider the following in your discussion post:
    What principles of patient confidentiality might be an issue? Consider legal and ethical.
    How might this nurse use a communication device to support safe patient practices?
    What would your organization’s policy on ‘personal communication device use in a patient care setting’ reveal related to this case? (If your organization does not have a written policy, or you are not currently working in an organization, what do you think should be included in such a policy and why?)

  • Angela is a 54-year-old married woman with three adult children.

    Case Study: CNS Prescriber Drug Therapy Plan for Depression
    Read the case study below and create a CNS Prescriber Care drug therapy plan for the patient with Depression.
    The patient presents to the clinic today for an annual checkup.
    Complaint: fatigue
    History: Angela is a 54-year-old married woman with three adult children. She has been the office manager of a small law firm for 20 years and has enjoyed her work until this past year. She has rheumatoid arthritis with minimal impairment that has been managed well with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). She has been taking conjugated estrogens for 8 years and decided to stop taking them because of her concern of their risks without sufficient medical benefit. She has tolerated the discontinuation without difficulty.
    Assessment: At her annual medical checkup appointment, she reports feeling tired all of the time, and she was gaining weight because she had no interest in her usual exercise activities and had been overeating, not from appetite but out of boredom. She denied that she and her husband have had marital difficulties beyond the ordinary and she was pleased with the achievements of her children. She noticed that she has difficulty falling asleep at night and awakens around 4 a.m. most mornings without her alarm and cannot go back to sleep even though she still feels tired. She finds little joy in her life but cannot pinpoint any particular concern. Although she denies suicidal feelings, she does not feel that there is meaning to her life: “My husband and kids would go on fine if I died and probably would not miss me that much.” The CNS asks Angela to fill out a Beck’s Depression Scale, which indicates that she has moderate depression.
    Answer the following questions related to this case study. Cite at least 3 current, peer-reviewed, scholarly sources in your answers and include a reference list. Cite at least one drug information resource (i.e., UpToDate, Micromedex, Lexicomp).
    What classes of drugs are used in the management of depression? .
    What would be the initial pharmacotherapy management plan for the patient’s depression?
    What are the monitoring parameters for a patient receiving an antidepressant?
    At the follow-up visit the patient reports no improvement in symptoms and states she stopped taking the citalopram (Celexa) because it wasn’t working. What additional information does the patient need regarding the achievement of results from an SSRI?
    The patient complains of morning nausea and vertigo while taking citalopram. What would be another pharmacotherapy treatment option?
    How soon should the patient return to the clinic after the change in medication for follow-up of drug effectiveness?
    After taking 2 weeks of escitalopram (Lexapro), Angela returns to the clinic for a follow-up visit. She states that she does not feel much different but may be less tired. She reports that the nausea and vertigo she experienced with citalopram has not occurred with escitalopram. What would be the next step in treatment?
    At what point should the provider consider tapering Angela off the SSRI therapy?
    Prepare a CNS Prescriber Drug Therapy Plan for the patient in this case study. See attached tool for completion.

    ANSWER
    What classes of drugs are used in the management of depression?

    There are several classes of drugs used in the management of depression, including:

    Selective serotonin reuptake inhibitors (SSRIs): SSRIs are the most commonly prescribed class of antidepressants. They work by increasing the levels of serotonin in the brain. Examples of SSRIs include citalopram (Celexa), escitalopram (Lexapro), fluoxetine (Prozac), sertraline (Zoloft), and paroxetine (Paxil).
    Serotonin-norepinephrine reuptake inhibitors (SNRIs): SNRIs work by increasing the levels of both serotonin and norepinephrine in the brain. Examples of SNRIs include venlafaxine (Effexor) and duloxetine (Cymbalta).
    Tricyclic antidepressants (TCAs): TCAs are an older class of antidepressants that are not as commonly prescribed as SSRIs or SNRIs because they have more side effects. However, TCAs can be effective for patients who do not respond to other antidepressants. Examples of TCAs include nortriptyline (Pamelor), amitriptyline (Elavil), and desipramine (Norpramin).
    Atypical antidepressants: Atypical antidepressants are a diverse group of drugs that work in different ways to improve mood. Examples of atypical antidepressants include bupropion (Wellbutrin), mirtazapine (Remeron), and trazodone (Desyrel).
    What would be the initial pharmacotherapy management plan for the patient’s depression?

    The initial pharmacotherapy management plan for the patient’s depression would include starting her on an SSRI, such as citalopram (Celexa) or escitalopram (Lexapro). SSRIs are the most commonly prescribed class of antidepressants because they are generally well-tolerated and have a low risk of side effects.

    The starting dose of citalopram is 20 mg once daily. The dose can be increased to 40 mg once daily after 1 week if needed. The starting dose of escitalopram is 10 mg once daily. The dose can be increased to 20 mg once daily after 1 week if needed.

    What are the monitoring parameters for a patient receiving an antidepressant?

    Patients receiving an antidepressant should be monitored for the following:

    Improvement in mood and depressive symptoms
    Emergence of suicidal thoughts or behaviors
    Side effects, such as nausea, vomiting, diarrhea, insomnia, agitation, and sexual dysfunction
    Patients should be seen for follow-up 2 weeks after starting an antidepressant and then every 4-6 weeks until their mood and depressive symptoms improve. Once the patient is stable, follow-up visits can be spaced out to every 3-6 months.

    At the follow-up visit the patient reports no improvement in symptoms and states she stopped taking the citalopram (Celexa) because it wasn’t working. What additional information does the patient need regarding the achievement of results from an SSRI?

    SSRIs can take several weeks to start working, so it is important for patients to be patient and continue taking the medication even if they do not feel better immediately. Patients should be educated about the expected onset of action of SSRIs and the importance of taking the medication as prescribed.

    Patients should also be informed that SSRIs can have side effects, such as nausea, vomiting, diarrhea, insomnia, agitation, and sexual dysfunction. These side effects are usually mild and go away on their own within a few weeks. However, if the side effects are severe or do not go away, the patient should contact their doctor.

    The patient complains of morning nausea and vertigo while taking citalopram. What would be another pharmacotherapy treatment option?

    Escitalopram (Lexapro) is another SSRI that is very similar to citalopram. Escitalopram is often well-tolerated by patients who experience side effects with citalopram.

    Other pharmacotherapy treatment options for depression include:

    SNRIs: SNRIs work by increasing the levels of both serotonin and norepinephrine in the brain. Examples of SNRIs include venlafaxine (Effexor) and duloxetine (Cymbalta).
    Atypical antidepressants: Atypical antidepressants are a diverse group of drugs that work in different ways to improve mood. Examples of atypical antidepressants include bupropion (Wellbutrin), mirtazapine (Remeron), and trazodone (Desyrel).
    The best pharmacotherapy treatment option for a patient with depression will depend on the individual patient’s response to treatment and side effects.

    How soon should the patient return to the clinic after the change in medication for follow-up of drug effectiveness?

    The patient should return to the clinic for a follow-up visit 2 weeks after starting escitalopram. This will give the medication enough time